Studies have also shown that TLR4 gene inactivation or gut sterilization can reduce HCC incidence by approximately 80%, whereas long‐term treatment with low‐dose LPS significantly accelerates HCC progression. Here, TLR4 is linked to hepatocellular carcinoma.